1. Rajalakshmi R., Santhi R., Elakkiya T. (2020) Synthesis and evaluation of novel oxazinyl thiazolidinone derivatives antioxidant agent as potent antidiabetic. Int. J. Adv. Sci. Technol., 29 (5), 1724–1733.
2. Cheddie A., Shintre S. A., Bantho A., Mocktar C., Koorbanally N. A. (2020) Synthesis and antibacterial activity of a series of 2-trifluoromethylbenzimidazole-thiazolidinone derivatives. J. Heterocycl. Chem., 57 (1), 299–307.
3. Mishchenko M., Shtrygol S., Kaminskyy D., Lesyk R. (2020) Thiazole-bearing 4-thiazolidinones as new anticonvulsant agents. Sci. Pharm., 88 (1), 16-30.
4. Ekinci A. S., Moncol J., Krishna V S., Sriram D., Özadali-Sari K. (2020) 5-Methyl-4-thiazolidinones, Synthesis and evaluation as antitubercular agents. J. Res. Pharm., 24 (1), 30–37.
5. Gawrońska-Grzywacz M., Popiołek Ł, Natorska-Chomicka D., Piątkowska-Chmiel I., Izdebska M., Herbet M., et al. (2019) Novel 2,3-disubstituted 1,3-thiazolidin-4-one derivatives as potential antitumor agents in renal cell adenocarcinoma. Oncol. Rep., 41 (1), 693–701.
6. Güzeldemirci N. U., Pehlivan E., Naesens L. (2018) Synthesis and antiviral activity evaluation of new 4-thiazolidinones bearing an imidazo2,1-b.thiazole moiety. Marmara Pharm. J., 22 (2), 237–248.
7. Gomathy S., Singh G., Gowramma B. Antony A. S., Elango K. (2012) Synthesis and anti-Parkinson′s screening of some novel 2-(naphthalen-1-yl)-N-2-substituted (4-oxothiazolidin-3-yl).acetamide derivatives. Int. J. Heal. Allied Sci.,1 (4), 244-248.
8. Panico A. M., Vicini P., Geronikaki A., Incerti M., Cardile V., Crascì L., et al. (2011) Heteroarylimino-4-thiazolidinones as inhibitors of cartilage degradation. Bioorg. Chem., 39 (1), 48–52.
9. Anekal D. P., Biradar J. S. (2017) Synthesis and biological evaluation of novel Indolyl 4-thiazolidinones bearing thiadiazine nucleus. Arab. J. Chem., 10 (suppl 2), S2098–S2105.
10. Shinde R. S., Masand V. H., Patil M. K. (2019) Antiinflammatory activity of triazine thiazolidinone derivatives, molecular docking and pharmacophore modeling. Indian J. Pharm. Sci., 81 (5), 851–858.
11. Incerti M., Crascì L., Vicini P., Aki E., Yalcin I., Ertan-Bolelli T., et al. (2018) 4-thiazolidinone derivatives as MMP inhibitors in tissue damage: Synthesis, biological evaluation and docking studies. Molecules, 23 (2), 1–18.
12. Bonn G. F., Otrzonsek G., Windsheimer F, Schneider B. (1980) Long-term antihypertensive therapy with Etozoline. Med. Welt., 31 (16), 603–607.
13. Ramirez M. A., Borja N. L. (2008) Epalrestat, An aldose reductase inhibitor for the treatment of diabetic neuropathy. Pharmacotherapy, 28 (5), 646–655.
14. Nirwan S., Chahal V., Kakkar R. (2019) Thiazolidinones, synthesis, reactivity, and their biological applications. J. Heterocycl. Chem., 56 (4), 1239–1253.
15. Rocha-Roa C., Molina D., Cardona N. (2018) A perspective on thiazolidinone scaffold development as a new therapeutic strategy for Toxoplasmosis. Front. Cell Infect. Microbiol., 8, 360-368.
16. Devinyak O., Zimenkovsky B., Lesyk R. (2013) Biologically active 4-thiazolidinones, a review of QSAR studies and QSAR modeling of antitumor activity. Curr. Top. Med. Chem.,12 (24), 2763–2784.
17. Jain A. K., Vaidya A., Ravichandran V., Kashaw S. K., Agrawal R. K. (2012) Recent developments and biological activities of thiazolidinone derivatives: A review. Bioorg. Med. Chem., 20 (11), 3378–3395.
18. Hamama W. S., Ismail M. A., Shaaban S., Zoorob H. H. (2008) Progress in the chemistry of 4- thiazolidinones. J. Heterocycl. Chem., 45 (4), 939–956.
19. Kumar A., Rajput C. S., Bhati S. K. (2007) Synthesis of 3-4′-(p-chlorophenyl)-thiazol-2′-yl.-2-(substituted azetidinone/thiazolidinone)-aminomethyl.-6-bromoquinazolin-4-ones as anti-inflammatory agent. Bioorg. Med. Chem., 15 (8), 3089–3096.
20. Sharma R. C., Kumar D. (2000) Synthesis of some new thiazolidin-4-ones as possible antimicrobial agents. J. Indian Chem. Soc., 77, 492–493.
21. Ojha S., Ameta U., Dhakar N., Talesara G. L. (2007) Synthesis and characterization of some alkoxypathalimide derivatives of benzotriazolythiadiazoles and benzotriazolyl thiazolidinones. Indian J. Chem.-Sect. B Org. Med. Chem., 46 (5), 860–865.
22. Vicini P., Geronikaki A., Incerti M., Zani F., Dearden J., Hewitt M. (2008) 2-heteroarylimino-5-benzylidene-4-thiazolidinones analogues of 2-thiazolylimino-5-benzylidene-4-thiazolidinones with antimicrobial activity: Synthesis and structure–activity relationship. Bioorg. Med. Chem., 16 (7), 3714–3724.
23. Ottanà R., Maccari R., Giglio M., Del Corso A., Cappiello M., Mura U., et al. (2011) Identification of 5-arylidene-4-thiazolidinone derivatives endowed with dual activity as aldose reductase inhibitors and antioxidant agents for the treatment of diabetic complications. Eur. J. Med. Chem., 46 (7), 2797–2806.
24. Verma P., Kamboj V. (2010) Synthesis and antidiabetic activity of N’-3-(alkyl/aryl substituted)-4-oxo-1,3 thiazolidin-2-yleidene.-2-(pyrazin-2-yloxy)acetohydrazide. Acta Pharm. Sci., 52 (4), 411–415.
25. Sharma P., Shrivastava B., Lamba H S., Sharma J., Sharma L. (2010) Synthesis and pharmacological study of 4-thiazolidinone derivatives. Int. J. Compr. Pharm., 3, 1-6.
26. Firke S. D., Firake B. M., Chaudhari R. Y., Patil V. R. (2009) Synthetic and pharmacological evaluation of some pyridine containing thiazolidinones. Asian J. Res. Chem., 2 (2), 157–160.
27. Imran M., Yar M. S., Khan S. A. (2009) Synthesis and antihyperglycemic activity of 2-(substituted phenyl)-3-{4-(1-naphthyl)-1,3-thiazol-2-yl-amino}-4-oxo-1,3-thiazolidin-5-ylacetic acid derivatives. Acta Pol. Pharm.-Drug Res., 66 (1), 51–56.
28. Kishore A., Nampurath G. K., Mathew S. P., Zachariah R. T., Potu B. K., Rao M. S., et al. (2009) Antidiabetic effect through islet cell protection in streptozotocin diabetes, A preliminary assessment of two thiazolidin-4-ones in Swiss albino mice. Chem. Biol. Interact., 177 (3), 242–246.
29. Nampurath G. K., Mathew S. P., Khanna V., Zachariah R. T., Kanji S., Chamallamudi M. R. (2008) Assessment of hypolipidaemic activity of three thiazolidin-4-ones in mice given high-fat diet and fructose. Chem. Biol. Interact., 171 (3), 363–368.
30. Singh T., Soni B. K., Reddy B. B.. (2011) Synthesis and evaluation of thiazolidinones derivatives for their pharmacological activity. Int. J. Res. Pharm. Biomed. Sci., 2, 1562–1567.
31. Deep A., Jain S., Sharma P. C. (2010) Synthesis and anti-inflammatory activity of some novel biphenyl-4- carboxylic acid 5-(arylidene)-2-(aryl)-4-oxothiazolidin-3-yl amides. Acta Pol. Pharm.-Drug Res., 67 (1), 63–6 7.
32. Barros C. D., Amato A. A., Oliveira T. B. de, Iannini K. B. R., Silva A. L. da, Silva T. G. da, et al. (2010) Synthesis and anti-inflammatory activity of new arylidene-thiazolidine-2,4-diones as PPARγ ligands. Bioorg. Med. Chem., 18 (11), 3805–3811.
33. Taranalli A., Bhat A., Srinivas S., Saravanan E. (2008) Antiinflammatory, analgesic and antipyretic activity of certain thiazolidinones. Indian J. Pharm. Sci., 70 (2), 159-164.
34. Ottanà R., Maccari R., Barreca M. L., Bruno G., Rotondo A., Rossi A., et al. (2005) 5-Arylidene-2-imino-4-thiazolidinones: Design and synthesis of novel anti-inflammatory agents. Bioorg. Med. Chem., 13 (13), 4243–4252.
35. Vigorita M., Ottanà R., Monforte F., Maccari R., Monforte M., Trovato A., et al. (2003) Chiral 3,3′-(1,2-ethanediyl)-bis2-(3,4-dimethoxyphenyl)-4-thiazolidinones with anti-inflammatory activity. Part 11, Evaluation of COX-2 selectivity and modelling. Bioorg. Med. Chem., 11 (6), 999–1006.
36. Dwivedi J., Devi K., Asmat Y., Jain S., Sharma S. (2016) Synthesis, characterization, antibacterial and antiepileptic studies of some novel thiazolidinone derivatives. J. Saudi Chem. Soc., 20 (suppl 1), S16–S20.
37. Rohini R. M., Manjunath M. (2012) Synthesis and anti-convulsant activity of triazothiole/thiazolyl thiazolidinone derivatives of indole. Der Pharma Chem., 4 (6), 2438–2441.
38. Velmurugan V., Leelavathi N., Kalvikkarasi S., Shanmuga P. S., Vijey A. M. (2012) Synthesis and anticonvulsant activity of thiazolidinone derivatives. J. Chem. Tech. Res., 4 (1), 1–4.
39. Gireesha M. K., Irfanali M., Srinivasulu N., Sathish N. K. (2010) Synthesis characterization and pharmacological activity of novel thiazolidin–4 one analogues. Orient J. Chem., 26 (3), 941–949.
40. Gursoy A., Terzioglu N. (2005) Synthesis and isolation of new regioisomeric 4-thiazolidinones and their anticonvulsant activity. Turkish J. Chem., 29, 247–254.
41. Mushtaque M., Avecilla F., Hafeez Z. B., Rizvi M. M. A. (2019) Synthesis, characterization, molecular docking, and anticancer evaluation of 4-thiazolidinone analogues. J. Heterocycl. Chem., 56 (6), 1794–805.
42. Holota S., Kryshchyshyn A., Derkach H., Trufin Y., Demchuk I., Gzella A., et al. (2019) Synthesis of 5-enamine-4-thiazolidinone derivatives with trypanocidal and anticancer activity. Bioorg. Chem., 86, 126–136.
43. Kumar A. S., Kudva J., Bharath B. R., Ananda K., Sadashiva R., Kumar S. M., et al. (2019) Synthesis, structural, biological and in silico studies of new 5-arylidene-4-thiazolidinone derivatives as possible anticancer, antimicrobial and antitubercular agents. New J. Chem., 43, 1597–1610.
44. Kulabaş N., Bingöl Özakpınar Ö., Özsavcı D., Leyssen P., Neyts J., Küçükgüzel İ. (2017) Synthesis, characterization and biological evaluation of thioureas, acylthioureas and 4-thiazolidinones as anticancer and antiviral agents. Marmara Pharm. J., 21 (2), 371–384.
45. Appalanaidu K., Kotcherlakota R., Dadmal T. L., Bollu V. S., Kumbhare R. M., Patra C. R. (2016) Synthesis and biological evaluation of novel 2-imino-4-thiazolidinone derivatives as potent anti-cancer agents. Bioorg. Med. Chem. Lett., 26 (21), 5361–5368.
46. Wang S., Zhao Y., Zhang G., Lv Y., Zhang N., Gong P. (2011) Design, synthesis and biological evaluation of novel 4-thiazolidinones containing indolin-2-one moiety as potential antitumor agent. Eur. J. Med. Chem., 46 (8), 3509–3518.
47. Havrylyuk D., Mosula L., Zimenkovsky B., Vasylenko O., Gzella A., Lesyk R. (2010) Synthesis and anticancer activity evaluation of 4-thiazolidinones containing benzothiazole moiety. Eur. J. Med. Chem., 45 (11), 5012–5021.
48. Lv P-C., Zhou C-F., Chen J., Liu P-G., Wang K-R., Mao W-J., et al. (2010) Design, synthesis and biological evaluation of thiazolidinone derivatives as potential EGFR and HER-2 kinase inhibitors. Bioorg. Med. Chem., 18 (1), 314–319.
49. Zhou H., Wu S., Zhai S., Liu A., Sun Y., Li R., et al. (2008) Design, synthesis, cytoselective toxicity, structure–activity relationships, and pharmacophore of thiazolidinone derivatives targeting drug-resistant lung cancer cells. J. Med. Chem., 51 (5), 1242–1251.
50. Kumar S., Kaur H., Kumar A. (2012) Synthesis of new azetidinonyl/thiazolidinonyl quinazolinone derivatives as antiparkinsonian agents. Arab. J. Chem., 5 (4), 475–484.
51. Kumar S., Kaur H., Saxena K. K., Sharrna M., Vishwakarma P., Kumar A. (2010) Synthesis and antiparkinsonian activity of some new adamantyl thiazolidinonyl/azeti-dinonyl indole derivatives. Indian J. Chem.-Sect. B Org. Med. Chem., 49 (10), 1398–1405.
52. Deep A., Jain S., Sharma P. C., Mittal S. K., Phogat P., Malhotra M. (2014) Synthesis, characterization and antimicrobial evaluation of 2,5-disubstituted-4-thiazolidinone derivatives. Arab. J. Chem., 7 (3), 287–291.
53. Desai N. C., Dodiya A., Shihory N. (2013) Synthesis and antimicrobial activity of novel quinazolinone–thiazolidine–quinoline compounds. J. Saudi Chem. Soc., 17 (3), 259–267.
54. Shukla S., Chogle M., Vaidya I. (2011) Synthesis of Novel 4-Thiazolidinone Derivatives with Anti-Inflammatory Activity. Int. J. Curr. Pharm. Res., 3, 85–88.
55. Vats V., Upadhyay R. K., Sharma P. (2010) Synthesis and Antifungal Activity of 2-ketophenyl-3-substituted aryl-1-thiazolidin-4-ones. E-Journal Chem., 7, 1040–1044.
56. Liesen A. P., de Aquino T. M., Carvalho C. S., Lima V. T., de Araújo J. M., de Lima J. G., et al. (2010) Synthesis and evaluation of anti-Toxoplasma gondii and antimicrobial activities of thiosemicarbazides, 4-thiazolidinones and 1,3,4-thiadiazoles. Eur. J. Med. Chem., 45 (9), 3685–3691.
57. Patel N. B., Shaikh F. M. (2010) Synthesis and antimicrobial activity of new 4-thiazolidinone derivatives containing 2-amino-6-methoxybenzothiazole. Saudi Pharm. J., 18 (3), 129–136.
58. Palekar V. S., Damle A. J., Shukla S. R. (2009) Synthesis and antibacterial activity of some novel bis-1,2,4-triazolo[3,4-b]-1,3,4-thiadiazoles and bis-4-thiazolidinone derivatives from terephthalic dihydrazide. Eur. J. Med. Chem., 44 (12), 5112–5116.
59. Bondock S., Khalifa W., Fadda A. A. (2007) Synthesis and antimicrobial evaluation of some new thiazole, thiazolidinone and thiazoline derivatives starting from 1-chloro-3,4-dihydronaphthalene-2-carboxaldehyde. Eur. J. Med. Chem., 42 (7), 948–954.
60. Gadre J. N., Nair S., Chitre S. (2007) Synthesis of some new 4-thiazolidinones and thiazin-4-ones as biologically potent agents. Indian J. Chem.-Sect. B Org. Med. Chem., 46 (4), 653–659.
61. Kumar P. R., Yadav M. S., Kumar M. M. K., Rao T. S. (2006) Synthesis and antimicrobial activity of some new substituted aryloxy-4-thiazolidinones. E- J. Chem., 3, 44–48.
62. Altintaş H., Ateş Ö., Birteksöz S., Ötük G., Uzun M., Şatana D. (2005) Synthesis of Mannich bases of some 2,5-disubstituted 4-thiazolidinones and evaluation of their antimicrobial activities. Turkish J. Chem., 29 (4), 425–435.
63. Mistry K. M., Desai K. (2004) Synthesis of novel heterocyclic 4-thiazolidinone derivatives and their antibacterial activity. E-J. Chem., 1, 189–193.
64. Ravichandran V., Jain A., Kumar K. S., Rajak H., Agrawal R. K. (2011) Design, Synthesis, and evaluation of thiazolidinone derivatives as antimicrobial and anti-viral agents. Chem. Biol. Drug Des., 78, 464–470.
65. Ravichandran V., Prashantha Kumar B. R., Sankar S., Agrawal R. K. (2009) Predicting anti-HIV activity of 1,3,4-thiazolidinone derivatives: 3D-QSAR approach. Eur. J. Med. Chem., 44 (3), 1180–1187.
66. Balzarini J., Orzeszko B., Maurin J. K., Orzeszko A. (2007) Synthesis and anti-HIV studies of 2-adamantyl-substituted thiazolidin-4-ones. Eur. J. Med. Chem., 42 (7), 993–1003.
67. Terzioǧlu N., Karali N., Gürsoy A., Pannecouque C., Leysen P., Paeshuyse J., et al. (2006) Synthesis and primary antiviral activity evaluation of 3-hydrazono-5-nitro-2-indolinone derivatives. Arkivoc, 2006 (1), 109–118.
68. Rawal R. K., Prabhakar Y. S., Katti S. B., De Clercq E. (2005) 2-(aryl)-3-furan-2-ylmethyl-thiazolidin-4-ones as selective HIV-RT inhibitors. Bioorg. Med. Chem., 13 (24), 6771–6776.
69. Barreca M. L., Chimirri A., De Luca L., Monforte A-M., Monforte P., Rao A., et al. (2001) Discovery of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti-HIV-1 agents. Bioorg. Med. Chem. Lett., 11 (13), 1793–1796.
70. Abo-Ashour M. F., Eldehna W. M., George R. F., Abdel-Aziz M. M., Elaasser M. M., Abou-Seri S. M., et al. (2018) Synthesis and biological evaluation of 2-aminothiazole-thiazolidinone conjugates as potential antitubercular agents. Future Med. Chem., 10 (12), 1405–1419.
71. Ilango K., Kumar S. A. (2010) Synthesis and antitubercular activity of novel 2-aryl N-(3,4,5-trihydroxybenzamido)-4-thiazolidinone derivatives. Rasayan J. Chem., 3, 493–496.
72. Srivastava T., Gaikwad A. K., Haq W., Sinha S., Katti S. B. (2005) Synthesis and biological evaluation of 4-thiazolidinone derivatives as potential antimycobacterial agents. Arkivoc, 2005 (2), 120–130.
73. Trivedi V. P., Undavia N. K., Trivedi P. B. (2004) Synthesis and biological activity of some new 4-thiazolidinone derivatives. J. Indian Chem. Soc., 81, 506–508.
74. Genc H., Ceken B., Bilen C., Sackes Z., Gencer N., Arslan O. (2017) Synthesis and biological evaluation of new 4-thiazolidinone derivatives as carbonic anhydrase inhibitors. Lett. Org. Chem., 14 (2), 80–85.
75. Adhikari A., Kalluraya B., Sujith K. V., Gouthamchandra K., Mahmood R. (2012) Microwave assisted synthesis of novel thiazolidinone analogues as possible bioactive agents. J. Adv. Res., 3 (4), 325–330.
76. Mushtaque M., Avecilla F., Azam A. (2012) Synthesis, characterization and structure optimization of a series of thiazolidinone derivatives as Entamoeba histolytica inhibitors. Eur. J. Med. Chem., 55, 439–448.